title: Evaluation of transfusion-related complications along with estimation of inhibitors in patients with hemophilia: A pilot study from a single center.
abstract: BACKGROUND
  Apart from inhibitor development in patients with hemophilia (PWH) the old problems of blood borne viral infections and red cell alloimmunization still persist in PWH from developing countries. This study was planned to detect the presence of inhibitors in our PWH and to determine the presence of transfusion transmitted infections (TTI) markers and clinically significant red cell alloantibodies in these patients.
  
  
  METHODS
  One hundred fourteen PWH were screened for various laboratory tests. Screening for inhibitors was done by mixing study. Blood grouping, TTI testing and red cell alloantibody detection were done as per the departmental standard operating procedures.
  
  
  RESULTS
  Out of 114 patients evaluated 98(86%) had hemophilia A and remaining 16(14%) had hemophilia B. Five (5.1%) patients of hemophilia A were positive on inhibitor screening. On Bethesda assay, one patient was high responder (14.4 BU/ml) and rest 4 were low responders (<5 BU/ml). Overall, 19 PWH were positive for TTI markers and two had clinically significant red cell alloantibody (anti-E and anti-Jk(b)).
  
  
  CONCLUSIONS
  This is probably first comprehensive study from our state on laboratory testing in PWH. The specialty of Transfusion Medicine can be a core part of hemophilia care. The overall prevalence of inhibitors in our hemophilia A patients was 5.1%, which is less as compared to majority of published studies.
authors.affiliation: Department of Transfusion Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
authors.forename: Anju
authors.initials: A
authors.lastname: Dubey
authors.forename: Anupam
authors.initials: A
authors.lastname: Verma
authors.forename: Priti
authors.initials: P
authors.lastname: Elhence
authors.forename: Prashant
authors.initials: P
authors.lastname: Agarwal
keywords: Hemophilia; inhibitor; transfusion-related complications
references.citation: Haemophilia. 2010 Jul 1;16(4):632-9
references.pmid: 20331753
references.citation: Indian J Med Res. 2000 Aug;112:61-4
references.pmid: 11037680
references.citation: Br J Haematol. 2007 Aug;138(3):305-15
references.pmid: 17614818
references.citation: Haemophilia. 2001 May;7(3):273-8
references.pmid: 11380631
references.citation: J Thromb Haemost. 2004 Jul;2(7):1047-54
references.pmid: 15219185
references.citation: J Biosci. 2003 Dec;28(6):783-9
references.pmid: 14660878
references.citation: Thromb Haemost. 2001 Mar;85(3):560
references.pmid: 11307831
references.citation: Blood. 2007 Jun 1;109(11):4648-54
references.pmid: 17289808
references.citation: Thromb Diath Haemorrh. 1975 Nov 15;34(2):612
references.pmid: 1198543
references.citation: Haemophilia. 2001 Nov;7(6):561-7
references.pmid: 11851754
references.citation: Semin Thromb Hemost. 2009 Nov;35(8):820-6
references.pmid: 20169519
references.citation: Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):651-5
references.pmid: 21406412